• Fluorinated CXCR4 Inhibitor A1 Surpasses Plerixafor in CRC M

  2026-06-11

  Khorramdelazad et al. introduce A1, a novel fluorinated CXCR4 inhibitor, demonstrating superior efficacy over AMD3100 (Plerixafor) in colorectal cancer models. Their integrative in silico, in vitro, and in vivo approach highlights A1’s potential to reshape targeted therapy for CRC by improving tumor suppression and immune modulation.

• Imipramine in Glioma and Apoptosis Research: Protocols & Ins

  2026-06-11

  Imipramine is redefining tricyclic antidepressant utility with proven efficacy in autophagy and apoptosis research. This article delivers protocol-driven guidance, workflow optimization, and troubleshooting tips for leveraging Imipramine in oncology and neurobiology studies.

• Phosphatase Inhibitor Cocktail 1 (100X in DMSO): Protocol Gu

  2026-06-10

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) enables rigorous preservation of protein phosphorylation states during cell and tissue lysate preparation, preventing unwanted dephosphorylation by endogenous phosphatases. Use this inhibitor cocktail in workflows requiring accurate analysis of protein phosphorylation, such as Western blotting or phosphoproteomics. It is not suitable for diagnostic or therapeutic applications.

• Precision Cy5 RNA Probe Synthesis: HyperScribe T7 Kit in Vir

  2026-06-10

  Explore how the HyperScribe T7 High Yield Cy5 RNA Labeling Kit empowers precise, high-yield synthesis of fluorescent RNA probes for dissecting viral phase separation and RNA-protein interactions. This in-depth article provides unique, actionable insights for advanced molecular virology applications.

• Nicotine Signaling and Chronic Kidney Disease Progression: M

  2026-06-09

  Jain and Jaimes (2013) provide a comprehensive mechanistic review linking nicotine signaling to the progression of chronic kidney disease (CKD) in smokers. Their synthesis demonstrates that nicotine, via non-neuronal nicotinic acetylcholine receptors, exacerbates renal injury through oxidative stress and pro-fibrotic mechanisms—spotlighting novel intervention points for CKD research.

• Forskolin as an Adenylate Cyclase Activator: Precision in Ce

  2026-06-09

  Forskolin enables precise, reproducible elevation of cAMP in stem cell, neuroendocrine, and cardiovascular research. This guide details optimized workflows, troubleshooting, and application-specific protocol parameters, drawing on recent innovations to maximize experimental reliability.

• Aprotinin in Cardiovascular Research: Protocols & Troublesho

  2026-06-08

  Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI) empowers precise control of serine protease activity, underpinning rigorous experimental workflows in blood management and inflammation models. This guide distills best practices, protocol enhancements, and troubleshooting insights to boost reproducibility and performance in cardiovascular and cell-based research.

• HyperScript™ Reverse Transcriptase: Enabling High-Resolution

  2026-06-08

  Explore how HyperScript™ Reverse Transcriptase empowers advanced cDNA synthesis for qPCR in adipogenesis and metabolic research. This article delivers unique scientific insight into RNA to cDNA conversion challenges in complex tissue models, drawing on recent mechanistic findings.

• Ceramide Metabolism Drives RGNNV Replication via Autophagy

  2026-06-07

  This study uses comprehensive lipidomics to demonstrate that red-spotted grouper nervous necrosis virus (RGNNV) manipulates ceramide metabolism in host cells, promoting viral replication through autophagy. These findings reveal new mechanistic targets for antiviral intervention in aquaculture and clarify the central role of ceramides in nodavirus pathogenesis.

• Vardenafil HCl Trihydrate: Precision in PDE5 Inhibition Assa

  2026-06-06

  Vardenafil HCl Trihydrate sets the standard for nanomolar-precision PDE5 inhibition, empowering researchers to dissect cGMP signaling and smooth muscle relaxation with unmatched selectivity. This practical guide spotlights optimized workflows, proteoform-resolved applications, and actionable troubleshooting strategies that drive reproducibility and insight.

• Transferring MoA Prediction with Machine Learning Across Cel

  2026-06-05

  Warchal et al. systematically evaluated machine learning classifiers for predicting compound mechanism of action (MoA) across genetically distinct cancer cell lines using high-content imaging. Their findings reveal that while deep learning and ensemble tree models perform similarly within a cell line, ensemble-based approaches transfer better across cell lines, highlighting key limitations and considerations for cross-line phenotypic screening.

• Dual-Action Kinase Inhibitors Accelerate p38α MAPK Dephospho

  2026-06-05

  This study reveals that certain kinase inhibitors not only block the active site of p38α MAP kinase but also promote its dephosphorylation by phosphatases, introducing a dual-action mechanism. These findings have significant implications for the design of more potent, selective inhibitors in inflammatory and signaling pathway research.

• Shionone Activates Mitophagy to Counter Pulmonary Fibrosis v

  2026-06-04

  This study uncovers that shionone, a terpenoid from Ligularia fischeri, alleviates pulmonary fibrosis by activating mitophagy through the PINK1-Parkin pathway. The research clarifies a mechanism linking mitochondrial quality control and reduced oxidative stress with anti-fibrotic outcomes, suggesting new therapeutic avenues for interstitial lung disease.

• Nelfinavir Mesylate: Bridging HIV Inhibition and Ferroptosis

  2026-06-04

  Explore how Nelfinavir Mesylate, a potent HIV-1 protease inhibitor, is redefining translational research by linking antiviral efficacy with innovative ferroptosis modulation. This article unpacks mechanistic insights, experimental strategies, and the evolving therapeutic landscape, empowering researchers to leverage Nelfinavir Mesylate for both HIV infection studies and emerging cell death paradigms.

• Protocol Use of HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-06-03

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus provides a reliable method for synthesizing high-yield, randomly Cy3-labeled RNA probes suitable for fluorescence-based detection in research settings. It addresses technical bottlenecks in RNA probe generation for in situ hybridization and Northern blotting, but is not validated for diagnostic or therapeutic use.

460 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page